LOADING
Comparing Broadcom Inc (AVGO) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.73T | $644.3B |
| P/E Ratio | 60.5 | 31.8 |
| Forward P/E | 19.4 | 23.5 |
| PEG Ratio | 0.41 | 4.79 |
| EPS | $6.02 | $8.42 |
| Revenue Growth (YoY) | 47.9% | 6.6% |
| Profit Margin | 38.9% | 21.5% |
| Return on Equity | 37.3% | 25.7% |
| Dividend Yield | 0.70% | 1.92% |
| Beta | 1.47 | 0.23 |
| 52-Week High | $494.18 | $276.47 |
| 52-Week Low | $285.06 | $170.33 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.